QURE (uniQure N.V.) Stock Financials & Earnings | Market Cap Arena

QURE (uniQure N.V.) Stock Financials & Earnings | Market Cap Arena

QUREuniQure N.V.

Mkt Cap$1B

Healthcare·Biotechnology·🇳🇱 Netherlands·NASDAQ

Revenue (TTM)$16M

Net Income (TTM)-$199M

EPS (TTM)-$3.48

Free Cash Flow (TTM)-$178M

Gross Margin89.5%

Op. Margin-1157.9%

Net Margin-1236.0%

FCF Margin-1105.5%

P/S Ratio (TTM)71.0x

P/E Ratio (TTM)—

YoY Rev Growth-40.6%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$5M	$3M	-$74M
Q2 23	$2M	$1M	-$65M
Q3 23	$1M	$401K	-$82M
Q4 23	$7M	-$2M	-$62M
Q1 24	$8M	-$741K	-$54M
Q2 24	$11M	$4M	-$44M
Q3 24	$2M	$1M	-$40M
Q4 24	$5M	$5M	-$46M
Q1 25	$2M	$1M	-$39M
Q2 25	$5M	$5M	-$44M
Q3 25	$4M	$3M	-$51M
Q4 25	$6M	$5M	-$52M

Valuation

Quarter	P/S	P/E
Q1 23	10.4x	—
Q2 23	10.2x	—
Q3 23	10.2x	—
Q4 23	72.1x	—
Q1 24	60.1x	—
Q2 24	41.2x	—
Q3 24	40.0x	—
Q4 24	42.1x	—
Q1 25	56.5x	—
Q2 25	79.7x	—
Q3 25	72.5x	—
Q4 25	71.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$78M	-$81M
Q2 23	-$57M	-$58M
Q3 23	$39M	$37M
Q4 23	-$50M	-$52M
Q1 24	-$61M	-$63M
Q2 24	-$33M	-$33M
Q3 24	-$37M	-$45M
Q4 24	-$53M	-$53M
Q1 25	-$44M	-$44M
Q2 25	-$40M	-$40M
Q3 25	-$16M	-$16M
Q4 25	-$78M	-$77M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$2M
Q2 23	$1M
Q3 23	$2M
Q4 23	$2M
Q1 24	$2M
Q2 24	$604K
Q3 24	$9M
Q4 24	$61K
Q1 25	$126K
Q2 25	$260K
Q3 25	$66K
Q4 25	$320K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+197.2%	+42.3%
Q2 23	+387.3%	+19.3%
Q3 23	-2.9%	+36.6%
Q4 23	-93.5%	-10.2%
Q1 24	+59.3%	-21.1%
Q2 24	+359.4%	-18.3%
Q3 24	+62.5%	-49.0%
Q4 24	-21.9%	-25.4%
Q1 25	-81.5%	-34.8%
Q2 25	-52.7%	-10.9%
Q3 25	+61.8%	+28.7%
Q4 25	+6.6%	+13.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$8M	151.4%
Q2 23	$9M	367.2%
Q3 23	$11M	788.7%
Q4 23	$7M	105.3%
Q1 24	$7M	84.7%
Q2 24	$7M	61.8%
Q3 24	$3M	150.3%
Q4 24	$5M	91.0%
Q1 25	$4M	281.4%
Q2 25	$5M	96.6%
Q3 25	$4M	95.2%
Q4 25	$5M	83.7%

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$61M	—	$18M
Q2 23	$46M	—	$21M
Q3 23	$65M	—	$18M
Q4 23	$42M	—	$17M
Q1 24	$41M	—	$14M
Q2 24	$34M	—	$16M
Q3 24	$31M	$12M	—
Q4 24	$39M	—	$9M
Q1 25	$36M	—	$11M
Q2 25	$35M	—	$14M
Q3 25	$34M	—	$19M
Q4 25	$35M	—	$22M

Revenue Segments

Quarter	Collaboration revenues	License revenues
Q3 24	$200K	$2M
Q4 24	$246K	$5M
Q1 25	—	$2M
Q2 25	—	$5M
Q3 25	$119K	$4M
Q4 25	$45K	$6M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$154M	$161M	$315M
Q2 23	$514M	$115M	$629M
Q3 23	$229M	$429M	$659M
Q4 23	$241M	$377M	$618M
Q1 24	$243M	$313M	$556M
Q2 24	$288M	$237M	$524M
Q3 24	$252M	$184M	$435M
Q4 24	$159M	$209M	$368M
Q1 25	$217M	$192M	$409M
Q2 25	$254M	$123M	$377M
Q3 25	$597M	$97M	$694M
Q4 25	$80M	$542M	$623M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	47M	+1.0%
Q2 23	48M	+0.4%
Q3 23	48M	+0.3%
Q4 23	48M	+0.1%
Q1 24	48M	+1.2%
Q2 24	49M	+0.5%
Q3 24	49M	+0.2%
Q4 24	49M	+0.3%
Q1 25	53M	+8.7%
Q2 25	55M	+3.2%
Q3 25	59M	+6.8%
Q4 25	58M	-1.7%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$35K	162
FY 15	$52K	198
FY 16	$100K	251
FY 17	$65K	202
FY 18	$53K	212
FY 19	$29K	248
FY 20	$113K	332
FY 21	$1M	463
FY 22	$213K	501
FY 23	$33K	480
FY 24	$130K	209
FY 25	$215	75K